Opening Neuroprotective Strategies in Stroke: Current Concepts and Future Directions
Neuroprotective Strategies in Stroke: Current Concepts and Future Directions
- Length
- 50 min
- Level
- Undergraduate
- Recorded
- University of Louisville2025
Chapter 1 of 7: Before the lecture
Traces neuroprotective strategies in stroke across excitotoxicity, oxidative stress, and trials.
PGY4 Scheduling Chief Neurology Resident, Dr. Hanah Alley presented "Neuroprotective Strategies in Stroke: Current Concepts and Future Directions"
PGY4 Scheduling Chief Neurology Resident, Dr. Hanah Alley presented "Neuroprotective Strategies in Stroke: Current Concepts and Future Directions"
Leading cause of mortality and morbidity worldwide
Agents/procedures that protect against neuronal injury
Memantine Enhances Recovery From Stroke
Memantine as a neuroprotective agent in ischemic stroke: Preclinical and clinical analysis
Prevention of Stroke and Myocardial Infarction by Amlodipine and Angiotensin Receptor Blockers: A Quantitative Overview
Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1)

This lecture
Talk 25 of 115 of UofL Neurology Grand Rounds.
Choose a node to see how it connects to this lecture. What comes before is on the leftat the top. What comes after is on the rightat the bottom. The ring is what it teaches. People and places are above. Other lectures and books are below.
Press a chosen node again to open it.
Your comment is kept while you sign up.Sign in
Safety and efficacy of $\mathrm{GABA}_A \alpha_5$ antagonist S44819 in patients with ischaemic stroke
Safety and efficacy of $\mathrm{GABA}_A$ antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial
Edaravone Dexborneol Versus Edaravone Alone for the Treatment of Acute Ischemic Stroke: A Phase III, Randomized, Double-Blind, Comparative Trial
Rationale and design of Treatment of Acute Ischemic Stroke with Edaravone Dexborneol II (TASTE-2): a multicentre randomised controlled trial
Ebselen Reduces Cytochrome c Release From Mitochondria and Subsequent DNA Fragmentation After Transient Focal Cerebral Ischemia in Mice
Oral Citicoline in Acute Ischemic Stroke: An Individual Patient Data Pooling Analysis of Clinical Trials
Impact of an immune modulator fingolimod on acute ischemic stroke
Combination of an Immune Modulator Fingolimod with Alteplase in Acute Ischemic Stroke: A Pilot Trial
miR-203 protects microglia mediated brain injury by regulating inflammatory responses via feedback to MyD88 in ischemia
Cyclosporin A ameliorates oxidative metabolism and infarct size in the endothelin-1 rat model of transient cerebral ischaemia
The Putative Drp1 Inhibitor Mdivi-1 is a Reversible Mitochondrial Complex I Inhibitor that Modulates Reactive Oxygen Species
Effects of Mdivi-1 on Mitochondrial Dysfunction and Mitochondria-Mediated Apoptosis in Ischemia-Reperfusion Injury After Stroke: A Systematic Review of Preclinical Studies
Cell-Based Therapy for Stroke: Musing With Muse Cells
Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial
Allogeneic Stem Cell Therapy for Acute Ischemic Stroke: The Phase 2/3 TREASURE Randomized Clinical Trial
Neuroprotective effects of nimodipine and nifedipine in the NGF-differentiated PC12 cells exposed to oxygen-glucose deprivation or trophic withdrawal
Metformin Alleviates Neuroinflammation Following Intracerebral Hemorrhage in Mice by Regulating Microglia/Macrophage Phenotype in a Gut Microbiota-Dependent Manner
Metformin ameliorates neuroinflammatory environment for neurons and astrocytes during in vitro and in vivo stroke and tobacco smoke chemical exposure: Role of Nrf2 activation
Azithromycin Affords Neuroprotection in Rat Undergone Transient Focal Cerebral Ischemia
Melatonin protects brain against ischemia/reperfusion injury by attenuating endoplasmic reticulum stress
Melatonin—A Potent Therapeutic for Stroke and Stroke-Related Dementia